However, the STAM mouse is recognized as a type 1 diabetes-related NASH model with hyperglycemia, reduced body weight gain, and lack of insulin secretion and fatty acid mobilization from adipose tissue. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.